The Maltese Competition Authority announces to the general public that a notification of a concentration between a drug development and manufacturing company and an injectables drug company has been filed (Gland Pharma / Phixen)

Competition Authority, Malta

Previous article The Hungarian Parliament recently adopts an amendment to the Hungarian Competition Act, which will enter into force on 1 January 2023 Next article The US Congress enacts significant changes to Hart-Scott-Rodino Act in terms of filing fees and disclosure requirements

30 Dec 2022

The Maltese Competition Authority announces to the general public that a notification of a concentration between a drug development and manufacturing company and an injectables drug company has been filed (Gland Pharma / Phixen)

KEYWORDS

Reference

Maltese Competition Authority, Gland Pharma / Phixen, Press release, 30 December 2022

Notification of Concentration* In terms of regulation 5(4) of the Control of Concentrations Regulations, 2002 published in Legal Notice 294 of 2002, the Director

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Malta Competition Authority
Malta Competition and Consumer Affairs Authority (Ħamrun)

Malta 10 contributions 454 visits

Quotation

Malta Competition Authority, The Maltese Competition Authority announces to the general public that a notification of a concentration between a drug development and manufacturing company and an injectables drug company has been filed (Gland Pharma / Phixen), 30 December 2022, e-Competitions January 2023 - II, Art. N° 110491

Visites 30